Terms: = Lung cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Treatment
44 results:
1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary cancer.
Chinchilla-Tábora LM; Montero JC; Corchete LA; González-Morais I; Del Barco Morillo E; Olivares-Hernández A; Rodríguez González M; Sayagués JM; Ludeña MD
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396726
[TBL] [Abstract] [Full Text] [Related]
2. HER2 and hla-a*02 dual CAR-T cells utilize LOH in a NOT logic gate to address on-target off-tumor toxicity.
Bassan D; Weinberger L; Yi J; Kim T; Weist MR; Adams GB; Foord O; Chaim N; Tabak S; Bujanover N; Lopesco Y; Vucci K; Schnair C; Levy-Knafo L; Kendall RL; Calzone FJ; Sharbi-Yunger A
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38097342
[TBL] [Abstract] [Full Text] [Related]
3. ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies.
Chervin AS; Stone JD; Konieczna I; Calabrese KM; Wang N; Haribhai D; Dong F; White MK; Rodriguez LE; Bukofzer GT; Ellis PA; Cosgrove C; Hecquet C; Clarin JD; Palma JP; Reilly EB
Mol Cancer Ther; 2023 Aug; 22(8):903-912. PubMed ID: 37294945
[TBL] [Abstract] [Full Text] [Related]
4. Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy.
Hattori T; Maso L; Araki KY; Koide A; Hayman J; Akkapeddi P; Bang I; Neel BG; Koide S
Cancer Discov; 2023 Jan; 13(1):132-145. PubMed ID: 36250888
[TBL] [Abstract] [Full Text] [Related]
5. Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.
Kim GB; Fritsche J; Bunk S; Mahr A; Unverdorben F; Tosh K; Kong H; Maldini CR; Lau C; Srivatsa S; Jiang S; Glover J; Dopkin D; Zhang CX; Schuster H; Kowalewski DJ; Goldfinger V; Ott M; Fuhrmann D; Baues M; Boesmueller H; Schraeder C; Schimmack G; Song C; Hoffgaard F; Roemer M; Tsou CC; Hofmann M; Treiber T; Hutt M; Alten L; Jaworski M; Alpert A; Missel S; Reinhardt C; Singh H; Schoor O; Walter S; Wagner C; Maurer D; Weinschenk T; Riley JL
Sci Transl Med; 2022 Aug; 14(660):eabo6135. PubMed ID: 36044599
[TBL] [Abstract] [Full Text] [Related]
6. Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting.
Kang HJ; Kwak YK; Kim M; Lee SJ
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3215-3223. PubMed ID: 36040666
[TBL] [Abstract] [Full Text] [Related]
7. Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Berner F; Niederer R; Luimstra JJ; Pop OT; Jochum AK; Purde MT; Hasan Ali O; Bomze D; Bauer J; Freudenmann LK; Marcu A; Wolfschmitt EM; Haen S; Gross T; Dubbelaar ML; Abdou MT; Baumgaertner P; Appenzeller C; Cicin-Sain C; Lenz T; Speiser DE; Ludewig B; Driessen C; Jörger M; Früh M; Jochum W; Cozzio A; Rammensee HG; Walz J; Neefjes J; Flatz L
Oncoimmunology; 2021; 10(1):2006893. PubMed ID: 34858733
[TBL] [Abstract] [Full Text] [Related]
8. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
9. Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade.
Correale P; Saladino RE; Giannarelli D; Giannicola R; Agostino R; Staropoli N; Strangio A; Del Giudice T; Nardone V; Altomonte M; Pastina P; Tini P; Falzea AC; Imbesi N; Arcati V; Romeo G; Caracciolo D; Luce A; Caraglia M; Giordano A; Pirtoli L; Necas A; Amler E; Barbieri V; Tassone P; Tagliaferri P
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554614
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer.
Akazawa Y; Saito Y; Yoshikawa T; Saito K; Nosaka K; Shimomura M; Mizuno S; Nakamoto Y; Nakatsura T
Cancer Sci; 2020 Aug; 111(8):2736-2746. PubMed ID: 32391625
[TBL] [Abstract] [Full Text] [Related]
11. Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Gridelli C; Ciuleanu T; Domine M; Szczesna A; Bover I; Cobo M; Kentepozidis N; Zarogoulidis K; Kalofonos C; Kazarnowisz A; Korozan M; de Las Penas R; Majem M; Chella A; Griesinger F; Bournakis E; Sadjadian P; Kotsakis A; Chinet T; Syrigos KN; Correale P; Gallou C; Jamet JM; Vetsika EK; Kosmatopoulos K; Georgoulias V;
Br J Cancer; 2020 May; 122(10):1461-1466. PubMed ID: 32210365
[TBL] [Abstract] [Full Text] [Related]
12. T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial cancers: A First-in-Human, Phase I/II Study.
Doran SL; Stevanović S; Adhikary S; Gartner JJ; Jia L; Kwong MLM; Faquin WC; Hewitt SM; Sherry RM; Yang JC; Rosenberg SA; Hinrichs CS
J Clin Oncol; 2019 Oct; 37(30):2759-2768. PubMed ID: 31408414
[TBL] [Abstract] [Full Text] [Related]
13. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell lung cancer.
Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
[TBL] [Abstract] [Full Text] [Related]
14. Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours.
Durgeau A; Virk Y; Gros G; Voilin E; Corgnac S; Djenidi F; Salmon J; Adam J; de Montpréville V; Validire P; Ferrone S; Chouaib S; Eggermont A; Soria JC; Lemonnier F; Tartour E; Chaput N; Besse B; Mami-Chouaib F
Nat Commun; 2018 Nov; 9(1):5097. PubMed ID: 30504837
[TBL] [Abstract] [Full Text] [Related]
15. An Isolated TCR αβ Restricted by hla-a*02:01/CT37 Peptide Redirecting CD8
Flores-Villanueva PO; Ganachari M; Guio H; Mejia JA; Granados J
J Immunol; 2018 Apr; 200(8):2965-2977. PubMed ID: 29555781
[TBL] [Abstract] [Full Text] [Related]
16. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
[TBL] [Abstract] [Full Text] [Related]
17. A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer.
Ofuji K; Tada Y; Yoshikawa T; Shimomura M; Yoshimura M; Saito K; Nakamoto Y; Nakatsura T
Int J Oncol; 2015 Feb; 46(2):497-504. PubMed ID: 25532027
[TBL] [Abstract] [Full Text] [Related]
18. [Cytotoxicity of T cells transduced with WT1 peptide-specific T-cell receptor gene against human lung cancer cells in vitro].
An J; Cai SW; Li Y; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1319-23. PubMed ID: 25263367
[TBL] [Abstract] [Full Text] [Related]
19. A phase II trial evaluating the clinical and immunologic response of hla-a2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.
Kotsakis A; Papadimitraki E; Vetsika EK; Aggouraki D; Dermitzaki EK; Hatzidaki D; Kentepozidis N; Mavroudis D; Georgoulias V
Lung Cancer; 2014 Oct; 86(1):59-66. PubMed ID: 25130084
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a novel hla-a 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.
Yoshimura M; Tada Y; Ofuzi K; Yamamoto M; Nakatsura T
Oncol Rep; 2014 Jul; 32(1):33-9. PubMed ID: 24842630
[TBL] [Abstract] [Full Text] [Related]
[Next]
